早期的异常性帕金森病与减少的循环RNA表达有关
Benjamin J Whittle1, Osagie G Izuogu2, Hannah Lowes3
1Wellcome Centre for Mitochondrial Research, Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
NPJ Parkinson's disease
|January 20, 2024
概括
这项研究发现,在早期帕金森症患者中,TMEM252和LMNB1基因表达增加.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 生物标志物发现发现
背景情况:
- 帕金森病 (PD) 的神经退行开始在临床诊断前几年.
- 全血中的RNA水平可能作为PD的早期生物标志物.
- 以前的研究已经探索了PD中的线性和循环RNA (circRNAs),但早期的大规模分析是有限的.
研究的目的:
- 在早期异常发病的帕金森病中对全血线性和循环RNA (circRNAs) 进行最大的量化.
- 为了确定新的RNA表达模式,并评估PD中circRNAs的诊断实用性.
- 研究RNA失调在PD先天免疫反应中的作用.
主要方法:
- 对来自两个独立队列的全血样本进行了RNA测序:PPMI (259名PD患者,161名对照) 和ICICLE-PD (48名PD患者,48名对照).
- 对线性和圆形RNA进行了差异基因表达分析.
- 使用统计分析来确定可复制的变化,并评估生物标志物潜力.
主要成果:
- 在PD患者中观察到TMEM252和LMNB1基因表达的可复制增加.
- 从ESYT2,BMS1P1和CCDC9的circRNA表达中发现了新的差异,并复制了之前报告的circRNA的趋势.
- 在两个PD队伍中发现circRNA表达的总体减少,RNASEL表达的增加,这表明激活了先天的抗病毒免疫反应.
结论:
- TMEM252和LMNB1基因表达是早期帕金森病的潜在生物标志物.
- 在这个早期的PD队列中,循环RNA没有在线性RNA上提供明显的诊断优势.
- 观察到的circRNA减少和增加的RNASEL表明PD病原和先天抗病毒免疫激活之间存在联系,突出显示了一种新的调节机制.
更多相关视频
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
7.5K
09:21Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
1.5K
相关概念视频
Parkinson's Disease: Overview
551
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
551
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
piRNA - Piwi-interacting RNAs
6.9K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.9K
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
Parkinson's Disease: Treatment
272
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
272
